Product Information

VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0806 per EA under NDC 68382003410. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Apr 14, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VENLAFAXINE HCL ER 37.5 MG CAP

venlafaxine hydrochloride
$0.0806per EA

Strength

37.5 mg/1

NDC

68382003410

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VENLAFAXINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090174

FDA Approved

4/14/2011

TE Code

AB

On Market Since

6/1/2011

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 45.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0806 per EA
All-time high$0.2892 (Mar 12, 2014)
All-time low$0.0712 (Nov 20, 2024)
52-week high$0.0909
52-week low$0.0791
Median price$0.1266
Average price$0.1244
Largest weekly change+52.8% (Feb 19, 2014)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+1.8%

1M

+1.8%

3M

+1.4%

6M

-6.9%

1Y

-10.0%

3Y

-18.5%

5Y

-36.2%

All

-45.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0806 per EA (NDC 68382003410), effective Nov 18, 2026.

How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?

Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has declined 45.6%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?

Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0712 (Nov 20, 2024) to a high of $0.2892 (Mar 12, 2014), with a median of $0.1266 per EA.

Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 37.5 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?

VENLAFAXINE HCL ER 37.5 MG CAP (NDC 68382003410) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.